Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia

• Published in: Respiratory medicine Vol. 132; pp. 189 - 194
• Main Authors: Yura, Hirokazu, Sakamoto, Noriho, Satoh, Minoru, Ishimoto, Hiroshi, Hanaka, Tetsuya, Ito, Chiyo, Hasegawa, Tomoko, Tanaka, Shin, Miyamura, Takuto, Nakashima, Shota, Hara, Atsuko, Kakugawa, Tomoyuki, Oda, Keishi, Kido, Takashi, Obase, Yasushi, Ishimatsu, Yuji, Yatera, Kazuhiro, Kawakami, Atsushi, Mukae, Hiroshi
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.11.2017; Elsevier Limited
• Subjects: Alveoli; Aminoacyl-tRNA ligase; Anti-synthetase syndrome; Antibodies; Bronchus; CD4 antigen; CD8 antigen; Connective tissues; Dermatomyositis; Idiopathic interstitial pneumonia; Lung diseases; Lymphocytosis; Patients; Pneumonia; Polymyositis; Pulmonary functions; Respiratory function; Sputum; tRNA; ILD; ARS; NSIP; ARS(+); PM/DM; Idiopathic interstitial pneumonia; Anti-synthetase syndrome; HRCT; ASS; OP; ARS(−); DAD; Dermatomyositis; BALF; CK; KL-6; VC; CT; IIP; Polymyositis; CTD; CADM; ALD; UIP; IPF
• ISSN: 0954-6111; 1532-3064
• DOI: 10.1016/j.rmed.2017.10.020

Anti-aminoacyl-tRNA synthetase (ARS) antibodies have been detected in patients with polymyositis/dermatomyositis (PM/DM) and are especially correlated with interstitial lung disease (ILD). The aim of this study was to clarify the clinical features of patients with anti-ARS antibody positive idiopathic interstitial pneumonias (IIPs). Patients were classified into three groups: 1) IIP with anti-ARS antibodies (ARS(+)IIP), 2) IIP without anti-ARS antibodies (ARS(−)IIP), and 3) PM/DM-associated ILD with anti-ARS antibodies (ARS(+)PM/DM-ILD). Clinical characteristics were compared retrospectively between the ARS(+)IIP group and the ARS(−)IIP group or ARS(+)PM/DM-ILD group. Eighteen ARS(+)IIP, 284 ARS(−)IIP, and 20 ARS(+)PM/DM-ILD patients were enrolled. The ARS(+)IIP group was significantly older and the male sex was predominant, had a lower prevalence of signs of connective tissue disease, differences in HRCT findings and patterns, and higher KL-6 levels compared to the ARS(+)PM/DM-ILD group. The findings in the bronchoalveolar lavage fluid (BALF) showing lymphocytosis and a lower CD4/CD8 ratio were similar between the two groups. However, the ARS(+)IIP group had significantly lower percentage of sputum, higher prevalence of mechanic's hand, higher KL-6 levels, lower percentage of vital capacity in the pulmonary function test, and lower CD4/CD8 ratio in BALF, compared to the ARS(−)IIP group. The present study demonstrated that features of pulmonary involvement were similar to those in the ARS(+)PM/DM-ILD group; however, some differences including HRCT findings and higher KL-6 levels suggest that ARS(+)IIP has severe ILD compared with ARS(+)PM/DM-ILD. Further prospective studies with a larger number of patients will elucidate the exact role of anti-ARS antibodies in IIPs. •Anti-ARS Ab were positive in 6.0% of patients with IIP.•Characteristics of ILD and BALF findings in ARS(+)IIP was similar vs. ARS(+)PM/DM-ILD.•ARS(+)IIP may have more severe ILD vs ARS(+)PM/DM-ILD, based on HRCT findings and higher KL-6 levels.•ARS(+)IIP has higher percentage of Mechanic's hand and NSIP pattern in HRCT vs. ARS(−)IIP.